Computer-aided diagnosis (CAD) is a technology used for the detection and characterization of cancer. Although CAD is not limited to a single type of cancer, a large number of CAD systems to date have been designed and used for breast cancer. The aim of this review is to discuss the current state of the CAD systems for breast-cancer diagnosis, their application as a second reader in clinical practice, and studies that have evaluated the effect of CAD on radiologists' performance.
Introduction
Mammography is currently the only recommended imaging method for breast-cancer screening [1, 2] . Mammography is especially valuable as an early detection tool because it can identify breast cancer at an early stage, before physical symptoms develop [3] . Early detection via mammographic screening and physical examination has demonstrated an improved survival from breast cancer in randomized controlled trials [1, 2] . The high sensitivity of mammography is, however, accomplished at a cost of low specificity. In order to reduce the number of false-negative diagnoses, lesions with a greater than 2% chance of being malignant will be recommended for biopsy [4] . As a result, only 15-30% of patients referred for biopsy are found to have a malignancy [4] [5] [6] . Unnecessary biopsies not only cause patient anxiety and morbidity, but also increase health-care costs. It is therefore important to improve the accuracy of interpreting mammographic lesions, thereby increasing the positive predictive value of mammography.
Computer-aided diagnosis (CAD) is becoming an increasingly important tool to assist radiologists in the process of interpreting mammograms. Current CAD systems in clinical use serve as a second reader for breastcancer detection. CAD systems for the classification of malignant and benign lesions are under development by a number of research groups.
To characterize breast lesions detected either clinically or at screening, ultrasound and magnetic resonance examinations are frequently recommended. Encouraged by the promising results of CAD for mammographic interpretation, many research groups have started to investigate the use of CAD for the interpretation of ultrasound and magnetic resonance imaging (MRI) of the breast.
This literature review is mainly focused on publications published since 2004 that include CAD observer studies and CAD methods.
Computer-aided diagnosis for screen-film mammography
The largest number of applications of CAD is currently for detecting lesions on screen-film mammography.
Helvie et al. [7 •• ] conducted a prospective clinical pilot trial of a non-commercial CAD system developed at the University of Michigan, USA, for screening mammogra-phy. A total of 2389 screening cases were read by 13 Mammography Quality Standards Act (MQSA) qualified radiologists in two academic institutions. Of the 11 cancers detected at screening in this patient cohort, the CAD system detected 10, and the radiologists also detected 10. One of the cancers detected by the CAD system was not initially seen by the radiologist (a 10% increase in the detection rate). There was a 10% increase in the call-back rate (from 14.4% to 15.8%) for the study cases involving CAD. In one of the institutions for which the call-back rate for non-study cases was available, this rate increased from 10.3% for non-study cases to 13.5% for study cases before the CAD marks were displayed.
In a medical-center setting, Birdwell et al. [8 •• ] evaluated 8682 cases without and with CAD. They performed 165 interventions and found 29 cancers. Twenty-one cancers were detected both by CAD and the radiologists, six were detected only by radiologists, and two were detected only by CAD. Radiologist-reading with CAD resulted in a 7.4% increase in the number of cancers detected. The increase in the recall rate resulting from CAD was 7.6%. A modest increase in the recall rate was observed for the study cases without CAD compared with the previous similar time period when radiologists interpreted the screening mammograms without having the CAD system present.
One interesting observation in the above two studies was that the radiologists' call-back rate for the study cases increased even before the CAD marks were displayed, indicating that radiologists might become more vigilant when they were aware that their reading would be compared with a second reading. Gur et al. [9 •• ] reported the results of a prospective study of CAD in their academic setting. Their study design compared the changes in breast-cancer detection rate and recall rate between two periods of time: before and after the CAD system was introduced into their screening-mammography practice. They found no statistically significant changes in the average recall and breast-cancer detection rates between the 56 432 cases read by 24 radiologists before the introduction of the CAD system and the 59 139 cases read after its introduction. These findings therefore appeared to differ from those of the previous studies.
The outcome of a study for evaluating the effects of CAD is expected to depend on a number of factors, such as the expertise of the radiologists using the system, the radiologists' vigilance in interpreting the CAD masks, and the study design. The study design used by Gur et al. [9 •• ] was different from the sequential-reading design of the above studies in that the statistics without and with CAD were obtained from different periods of time. The change, if any, in a radiologist's decision caused by CAD was not recorded for individual cases or individual readers. This design thus yields a global average of the effects from many factors that may influence the cancer-detection rate. For example, Gur et al.
[9 •• ] reported that the proportion of patients who were screened for the first time decreased from about 40 to 30% during the entire study period. Potential differences in the demographics of the two patient cohorts recruited in the two periods might also contribute variances to the breast-cancer detection and recall rates. It is not known whether any differences between the two patient cohorts might have masked the potential change in the breast-cancer detection rate arising from the use of CAD.
Hadjiiski et al.
[10 •• ] evaluated the effects of CAD on radiologists' characterization of masses on serial mammograms using 253 temporal image pairs (138 malignant and 115 benign) obtained from 96 patients who had a mass on serial mammograms. Eight radiologists and two breast-imaging fellows assessed the temporal pairs with and without computer aid. Receiver operating characteristic (ROC) methodology was used to analyse classification performance. The average area under the ROC curve, A z , for radiologists' estimates of the likelihood of malignancy was 0.79 without CAD and improved to 0.84 with CAD. The improvement was statistically significant (P = 0.005). On the basis of Breast Imaging Reporting and Data System (BI-RADS) assessments, it was estimated that, with CAD, each radiologist on average reduced the number of unnecessary biopsies by on average 0.7% and correctly recommended 5.7% additional biopsies.
Destounis et al. [11 •• ] retrospectively evaluated the role of CAD in reducing the rate of false-negative findings on screening mammograms considered normal at initial double-reading. The CAD correctly marked 71% of the 52 actionable findings read as negative in the previous screening year. This shows the potential of CAD to reduce the false-negative rate at double-reading.
The effect of CAD on the detection of clinically unsuspected breast cancers was studied by Butler et al.
Breast cancers occurred at a location other than the site of the presenting clinical finding in 15% (30/197) of the patients in whom cancer was detected. CAD identified 87% of these incidentally detected cancers and may have been useful as an aid to the radiologists.
In an observer experiment with five radiologists and 185 patients, Marx et al. [13 •• ] recorded an increase in the short-term call-back rate ranging between 5 and 7% when the cases were evaluated with CAD. With CAD, they also observed a reduced number of recommended unnecessary biopsies (range 12-34%).
Baker et al. [14 • ] studied the consistency of a commercial CAD system by scanning the mammograms 10 times and evaluating the prompts from the CAD system. They concluded that there was an inconsistency in the CAD analysis for the breast cancers detected at screening; the CAD system was, however, reasonably consistent in the overall number of cancers identified at different runs. Greater variability was observed for the false-positive marks than for the true-positive marks.
Two commercial and one in-house CAD scheme were compared by Gur et al.
[15 • ] on 219 patients. The massdetection rate for the systems varied between 67 and 72%, and the differences were not statistically significant. The differences in the false-positive rate were statistically significant, however, ranging from 1.08 to 1.68 per four view examinations. 
Computer-aided diagnosis for full-field digital mammography

Computer-aided diagnosis for breast ultrasound
A number of CAD schemes have been proposed for the characterization of malignant and benign breast lesions on ultrasound scans.
Sahiner et al. [18 •• ] designed a CAD system for characterizing breast masses as malignant or benign on threedimensional ultrasound scans using 102 biopsied masses. Four radiologists evaluated the three-dimensional ultrasound volumes in an observer study. The CAD system based on the three-dimensional segmentation method achieved an area under ROC curve, A z , of 0.92 for testing. The A z values of the four radiologists ranged from 0.84 to 0.92. The accuracy of the classifier designed for differentiating malignant and benign breast masses on three-dimensional ultrasound volumes in this study was similar to that of experienced breast radiologists.
A two-stage CAD system that first detected the lesions on ultrasound images and then classified the lesion by distinguishing the cancer from all other lesions was de-veloped by Drukker et al. [19 •• ] . Four hundred cases were used for training and 485 cases for testing. The A z for the task of distinguishing the true lesions and false-positives was 0.94 and 0.91 for the training and testing datasets, respectively. For the task of classifying cancer from all other detections, the A z was 0.87 and 0.81 for the training and testing data sets, respectively.
Sahiner et al.
[20 •• ] designed a combined three-dimensional ultrasound and mammographic CAD system using 67 patients and performed an observer study with five radiologists. The A z of the combined CAD system was 0.91. The radiologists significantly improved (P = 0.03) their average performance to an A z of 0.95 when using combined CAD.
Drukker et al.
[21 •• ] also designed a CAD system combining ultrasound and mammographic information. The system was evaluated on a dataset of 100 lesions from 97 patients with available mammograms and ultrasound images. The A z for the combined system was 0.92, which represented a statistically significant improvement compared with the mammography system alone ( A z = 0.77) and the ultrasound system alone (A z = 0.88).
Additional CAD systems for classifying breast masses as malignant or benign on ultrasound images were reported by Joo et al. . The CAD systems were based on artificial intelligence techniques (support vector machines and artificial neural networks) and developed with datasets of different sizes (between 54 and 584 cases). The classification accuracy A z obtained with these CAD systems ranged from 0.86 to 0.95.
Computer-aided diagnosis for magnetic resonance imaging of the breast MRI has recently been used more frequently for the diagnosis of breast cancer. A number of studies have been reported that have explored the feasibility of CAD use for characterizing breast lesions as malignant or benign using contrast-enhanced MRI.
Deurloo et al. [26 •• ] designed a computer system to estimate the likelihood of the malignancy of lesions on contrast-enhanced MRI images. They used 100 lesions (in 78 patients) to train the computer system. In addition, they had the descriptive rating (benign, probably benign, indeterminate, suspicious, or highly suggestive of malignancy) of the lesions on MRI by an experienced radiologist. The scores from the computer system and the radiologist were merged by using logistic regression analysis into a combined model. The model was tested on an independent set of 72 clinically and mammographically occult lesions in 60 patients. The A z values for the radiologist's readings, the computer system and the combined model were 0.86, 0.85, and 0.91, respectively. The study demonstrated that complementary information from a radiologist and a computer system has the potential to increase the overall performance for clinically and mammographically occult lesions.
Malignant and benign classification on T1-weighted three-dimensional spoiled gradient-echo sequence with and without intravenously injected contrast was performed by Chen et al. [27 •• ] . A dataset of 121 cases (77 malignant and 44 benign) was used. Features related to morphology, enhancement kinetics, and the course of enhancement-variation over the lesion were extracted from both the hand-outlined and automatic computersegmented lesion contours. The classification accuracy in terms of A z using a linear classifier was 0.80 and 0.86 for the hand-segmented and computer-segmented contours, respectively.
Nattkemper et al. [28 • ] developed a classifier to distinguish between malignant and benign breast masses using MRI data from 74 cases (49 malignant and 25 benign). They extracted contour-type and wash-out-type features determined by radiologists from dynamic contrast-enhanced MRI time-course data. Using a support vector machine classifier, they obtained an A z of 0.88.
DeMarini et al. [29 • ] evaluated 15 patients with 16 newly diagnosed locally advanced breast cancers using MRI before and after neoadjuvant chemotherapy. CAD assessments, including the presence or absence of significant enhancement, enhancement profiles, and maximum sizes, were recorded. Prior to chemotherapy, all tumors demonstrated CAD-assessed significant enhancement. Following chemotherapy, the results showed a decrease in wash-out enhancement in patients with minimal residual malignancy at pathology. Seven of the 16 tumors, however, showed no residual significant enhancement after chemotherapy, although all had residual disease at pathology. In this patient population, CAD for breast MRI may complement, but should not replace, the careful assessment of tumors by the radiologist.
Computer-aided diagnosis for new modalities -breast tomosynthesis
Digital breast tomosynthesis (DBT) is a promising new modality allowing three-dimensional imaging of the breast.
Chan et al. [30 • ,31 •• ] have developed a CAD system for breast masses on DBT mammograms. Twenty-six cases obtained with a prototype DBT system were used. The CAD system first screened the three-dimensional volume for candidates for a mass by gradient-field analysis. Each candidate was segmented from the structured background, and morphological and texture features were extracted. A feature classifier was designed to differentiate true masses from normal tissues. The CAD system was trained and tested using a leave-one-caseout method. The classifier obtained an area under the test ROC curve of 0.91 ± 0.03 SD. The CAD system achieved a sensitivity of 85% with a rate of 2.2 false positives per case. The results demonstrate the feasibility of this approach for the development of a CAD system for DBT mammograms. Reiser et al. [32 •• ] presented initial results for a computerized mass-lesion-detection scheme for DBT images. The algorithm used a radial gradient index feature for the initial detection of the lesion and for the segmentation of lesion candidates. A set of features was extracted for each segmented partition. The performance of twodimensional and three-dimensional features was compared. For gradient features, the additional dimension provided no improvement in classification performance. For shape features, classification using three-dimensional features was improved compared with the equivalent two-dimensional features. The system was designed using a leave-one-case-out method on 21 DBT cases. The preliminary overall performance was 76% sensitivity with 11 false positives per case. Breast density is a risk factor for developing breast cancer. Wei et al. [36 •• ] used an automated CAD system to estimate breast density on mammograms. The system estimated breast density using histogram analysis [37] . Wei et al. evaluated the correlation between the percentage dense area on the mammogram and the percentage glandular tissue volume as estimated from MRI images. The correlation was high, which indicated that changes in mammographic density might be a useful indicator of changes in the volume of fibroglandular tissue in the breast.
Development of computer-aided diagnosis for breath cancer -new methods and approaches
Li et al. [38 •• ] developed computerized texture analysis of mammograms that provided radiographic descriptors of mammographic parenchymal patterns; this may be useful for identifying women at high risk for breast cancer and for monitoring the treatment of breast-cancer patients.
Brem et al. [39 •• ] studied the effect of breast density on CAD performance. They found no statistically significant difference in breast-cancer detection between dense and non-dense breasts. The false-positive rate for the detection of masses was, however, lower in non-dense breasts than in dense breasts. The authors suggested that CAD might be particularly advantageous in patients with dense breasts, in whom mammography is most challenging.
Brem et al. [40 • ,41 • ] also studied the effect of cancer size and tumor histopathology on CAD detection performance. They found that CAD detection performance did not strongly depend on cancer size and tumor histopathology, and that the CAD system correctly marked a large majority of the biopsy-proven breast cancers.
An area of active CAD research is the improvement of algorithms for breast-mass detection. Catarious et al.
[42 • ] and Timp et al. [43 • ] have developed methods to improve the segmentation of breast masses using iterative linear segmentation, and segmentation based on dynamic programming, respectively. Wei et al. [44 • ] have proposed a dual-CAD-system approach to the detection of subtle masses. An improvement in detection sensitivity by 2-10% without an increase in false-positive marks was achieved.
Soo et al. [45 • ] used a commercial system to detect amorphous calcifications, which usually are difficult for radiologists to detect. The case sensitivity of CAD was found to be relatively low, at 51%, with two false-positives per case.
Breast lesion characterization is also an important topic of CAD research. Bilska-Wolak et al. [46 • ] designed a likelihood ratio classifier for classifying masses as malignant or benign and tested its performance on an independent data set. A test A z of 0.90 was obtained. Lim et al. [47] developed a classifier using generalized dynamic fuzzy neural networks and texture features. They obtained an A z of 0.87 for the classification of malignant and benign masses. 
Conclusion
CAD is an active area of research and development in medical imaging and diagnostic radiology. There have recently been an increased number of CAD applications. To date, the largest number of CAD systems have been developed for screening mammography. An increasing number of applications for ultrasound and MRI breast imaging are, however, being evaluated. Although most clinical applications are currently devoted to detecting breast cancer, it is to be expected that CAD characterization will be an important component of the next generation of CAD systems.
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